Amlodipine Besylate Tablet
Product Images NDC 43353-989
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 43353-989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Fig1 (Fig1)
This is a statistical analysis output for an event rate. It includes information about the p-value, hazard ratio, and confidence intervals. It also includes a graph which seems to show the event rate over time in months. However, the information provided is incomplete and it is hard to provide a full description without further details.*
Fig2 (Fig2)
This appears to be a table or graph of data related to a clinical trial study comparing Favars Amlodipine and Placebo in individuals with some form of vessel disease who may or may not have undergone PCI-stent treatment. The table includes information on the gender, sitting SEP, number of vessels with stenosis, and PCI-stent strata of the participants. The graph seems to show the hazard ratio for the two treatments over time, with a baseline sitting SEP of 120 mmHg.*
Structure (Ima)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.